146 related articles for article (PubMed ID: 29285354)
1. Thymidine phosphorylase expression and prognosis in colorectal cancer treated with 5-fluorouracil-based chemotherapy: A meta-analysis.
Che J; Pan L; Yang X; Liu Z; Huang L; Wen C; Lin A; Liu H
Mol Clin Oncol; 2017 Dec; 7(6):943-952. PubMed ID: 29285354
[TBL] [Abstract][Full Text] [Related]
2. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
Tokunaga Y; Takahashi K; Saito T
Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763
[TBL] [Abstract][Full Text] [Related]
3. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
Yamada H; Iinuma H; Watanabe T
Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of thymidine phosphorylase/platelet-derived endothelial cell growth factor in advanced colorectal cancer after surgery: evaluation with a new monoclonal antibody.
Tokunaga Y; Hosogi H; Hoppou T; Nakagami M; Tokuka A; Ohsumi K
Surgery; 2002 May; 131(5):541-7. PubMed ID: 12019408
[TBL] [Abstract][Full Text] [Related]
6. Correlations between expression levels of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase, and efficacy of 5-fluorouracil-based chemotherapy for advanced colorectal cancer.
Bai W; Wu Y; Zhang P; Xi Y
Int J Clin Exp Pathol; 2015; 8(10):12333-45. PubMed ID: 26722420
[TBL] [Abstract][Full Text] [Related]
7. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
Ikeguchi M; Makino M; Kaibara N
Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
[TBL] [Abstract][Full Text] [Related]
8. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
[TBL] [Abstract][Full Text] [Related]
9. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.
Ijuin T; Nibu K; Doi K; Inoue H; Saitoh M; Ohtsuki N; Makino K; Amatsu M
Acta Otolaryngol; 2007 Mar; 127(3):305-11. PubMed ID: 17364369
[TBL] [Abstract][Full Text] [Related]
10. Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis.
Zhao F; Yuan X; Ren D; Shen G; Wang Z; Zheng F; Ahmad R; Ma Z; Zhao J
J Environ Pathol Toxicol Oncol; 2019; 38(1):21-28. PubMed ID: 30806287
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the potential value of 5-fluorouracil metabolic enzymes in predicting prognosis and treatment response of colorectal cancer patients.
Gajjar KK; Vora HH; Kobawala TP; Trivedi TI; Ghosh NR
Int J Biol Markers; 2018 May; 33(2):180-188. PubMed ID: 29799355
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
[TBL] [Abstract][Full Text] [Related]
13. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes.
Gustavsson B; Kaiser C; Carlsson G; Wettergren Y; Odin E; Lindskog EB; Niyikiza C; Ma D
Int J Cancer; 2009 Mar; 124(5):1220-6. PubMed ID: 19051292
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase expression and efficacy of adjuvant doxifluridine in advanced colorectal cancer patients.
Hasegawa S; Seike K; Koda K; Takiguchi N; Oda K; Hasegawa R; Miyazaki M
Oncol Rep; 2005 Apr; 13(4):621-6. PubMed ID: 15756433
[TBL] [Abstract][Full Text] [Related]
16. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.
Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Liu J; Xu H; Wang Z
BMC Cancer; 2014 Dec; 14():976. PubMed ID: 25519477
[TBL] [Abstract][Full Text] [Related]
17. Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer.
Ishii R; Takiguchi N; Oda K; Koda K; Miyazaki M
Int J Oncol; 2001 Oct; 19(4):717-22. PubMed ID: 11562746
[TBL] [Abstract][Full Text] [Related]
18. [Transfection of thymidine phosphorylase cDNA with lentiviral vector enhances the anticancer effect of 5'-deoxy-5-fluorouridine on colorectal cancer cell lines HT29 and LS174T].
Ye D; Wang Q; Zhang J; Liu Q
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):18-24. PubMed ID: 25877313
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic role of circulating YKL-40 in endometrial carcinoma patients: a meta-analysis of seven related studies.
Cheng D; Sun Y; He H
Med Oncol; 2014 Dec; 31(12):326. PubMed ID: 25412935
[TBL] [Abstract][Full Text] [Related]
20. Determination of thymidine phosphorylase expression level facilitates recurrence risk stratification in stage II/III colorectal cancer following adjuvant chemotherapy with oral fluoropyrimidines.
Kugimiya N; Harada E; Suehiro Y; Suga A; Takemoto Y; Hamano K
Oncol Lett; 2019 Jun; 17(6):5267-5274. PubMed ID: 31186743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
